Sequenom Laboratories Announces National Coverage Agreement With UnitedHealthcare Insurance Company For Prenatal Diagnostic Testing Services
SAN DIEGO, Sept. 17, 2015 Sequenom Laboratories, a wholly owned subsidiary of Sequenom, Inc. (SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced today that it has signed a national agreement with UnitedHealthcare Insurance Company, effective October 1, 2015, covering 43 million people throughout the United States, to provide the MaterniT21® PLUS, HerediT® CF Carrier Screen and HerediT® UNIVERSAL Carrier Screen laboratory-developed tests (LDT). The addition of this contract brings the number of covered lives under agreement by Sequenom Laboratories' diagnostic services to more than 200 million.
- Published: 17 September 2015
- Written by Editor